|21.90|| +0.005 / +0.02%|
MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the following segments: Partnered Discovery, Proprietary Development and AbD Serotec. The Partnered Discovery segment involves technologies for the generation of human antibody therapeutics, which are exploited through partnerships with pharmaceutical and biotechnology companies. The Proprietary Development segment includes activities relating to proprietary therapeutic antibody development. The AbD Serotec segment leverages the company's core technological capabilities in the design and manufacture of antibodies for research and diagnostic purposes. The company was founded by Andreas Plückthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.
|Simon E. Moroney||Chief Executive Officer|
|Jens Holstein||Chief Financial Officer|
|Marlies Sproll||Chief Scientific Officer|
|Ludger Langer||Head-Clinical Operations & Project Management|
|Günter Wellnhofer||Head-Technical Operations & Information Technology|